Transaction · 0001193125-26-389550

Reid Laurence

Reid Laurence, DIR, reported an open-market or private purchase at Metagenomi Therapeutics, Inc. involving 19883.000000 shares for an estimated $23263.11. Reported holdings after the transaction were 19883.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
MGXMetagenomi Therapeutics, Inc.
Trade date
Sep 09, 2026
Filing date
Sep 11, 2026
View on SEC Insider profile
Disclosed value$23.2kShares × reported price
Shares traded19.8k$1.17 per share
Holdings after19.8kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

New position: there is no prior reported position to use as a percentage baseline.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MGX price since this filing

Daily closing prices, with the filing date and available return windows
MGX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -4.3%30d -13.0%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-389550
Common Stock
Transaction date
Sep 09, 2026
Filed Sep 11, 2026, 11:51 PM · 2d delay
Shares
19,883 sh
$1.17 per share
Estimated value
$23.2k
Computed from shares × price
Holdings after
19,883 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Director Buy Direct Ownership Large Holdings Increase
Filing-only score

+36 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.165 to $1.175. Full information regarding the number of shares…

Original filing · 0001193125-26-389550
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MGX